Affiliation:
1. Shanghai Municipal Center for Disease Control & Prevention
Abstract
Abstract
BACKGROUND: The prevalence of high birth weight or large for gestational age (LGA) infants is increasing, with increasing evidence of pregnancy-related factors that may have long-term impacts on the health of the mother and baby. Here, we aimed to determine the association between excessive fetal growth and subsequent maternal cancer. METHODS: We performed a population-based, prospective, cohort study to explore the association between excessive fetal growth, specifically LGA and macrosomia, and maternal cancer after childbirth. The data set was based on two registry systems: the Shanghai Birth Registry (SBR) and the Shanghai Cancer Registry (SCR), with medical records from the Shanghai Health Information Network (SHIN) as a supplement. Cox proportional hazard models were used to estimate associations. RESULTS: The prevalence of macrosomia and LGA in women who developed cancer was higher than that in women who did not develop cancer. Having a LGA child in the first delivery was associated with a subsequently increased risk of maternal cancer (HR=1.08, CI: 1.04–1.11). Additionally, in the last and heaviest deliveries, there were similar associations between the birth of LGA and maternal cancer rates (HR=1.08, 95%CI: 1.04–1.12; HR=1.08, 95%CI: 1.05–1.12, respectively). Furthermore, a substantially increased trend in the risk of maternal cancer was associated with an increase in birth weight of over 2500 g. CONCLUSIONS: Our study provided strong support for the association between LGA births and increased risks of maternal cancer. The risk for maternal cancer after birth of excessive fetal growth may need further consideration.
Publisher
Research Square Platform LLC
Reference33 articles.
1. Prediction of fetal growth based on maternal serum concentrations of human chorionic gonadotropin, human placental lactogen and estriol;Markestad T;Acta Obstet Gynecol Scand Suppl,1997
2. Maternal serum concentrations of human placental lactogen, estradiol and pregnancy specific beta 1-glycoprotein and fetal growth retardation;Gardner M;Acta Obstet Gynecol Scand Suppl,1995
3. The role of pregnancy, perinatal factors and hormones in maternal cancer risk: a review of the evidence;Troisi R;J Intern Med,2018
4. Maternal breast cancer risk in relation to birthweight and gestation of her offspring;Swerdlow AJ;Breast Cancer Res,2018
5. Fetal growth and subsequent maternal risk of thyroid cancer[J];Crump C;Int J Cancer,2016